These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9849582)

  • 1. Expression of CD44 variants and its association with survival in pancreatic cancer.
    Gotoda T; Matsumura Y; Kondo H; Saitoh D; Shimada Y; Kosuge T; Kanai Y; Kakizoe T
    Jpn J Cancer Res; 1998 Oct; 89(10):1033-40. PubMed ID: 9849582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients.
    Li Z; Chen K; Jiang P; Zhang X; Li X; Li Z
    Diagn Pathol; 2014 Apr; 9():79. PubMed ID: 24708709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 variant isoform expression and breast cancer prognosis.
    Tokue Y; Matsumura Y; Katsumata N; Watanabe T; Tarin D; Kakizoe T
    Jpn J Cancer Res; 1998 Mar; 89(3):283-90. PubMed ID: 9600122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma.
    Gotoda T; Matsumura Y; Kondo H; Ono H; Kanamoto A; Kato H; Watanabe H; Tachimori Y; Nakanishi Y; Kakizoe T
    Gut; 2000 Jan; 46(1):14-9. PubMed ID: 10601048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prognostic factors of pancreatic cancer--adhesion molecule CD44].
    Gotoda T; Matsumura Y; Kokawa A; Kondo H
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2036-42. PubMed ID: 9838904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Tumor Growth and Metastasis in Pancreatic Cancer Models by Interference With CD44v6 Signaling.
    Matzke-Ogi A; Jannasch K; Shatirishvili M; Fuchs B; Chiblak S; Morton J; Tawk B; Lindner T; Sansom O; Alves F; Warth A; Schwager C; Mier W; Kleeff J; Ponta H; Abdollahi A; Orian-Rousseau V
    Gastroenterology; 2016 Feb; 150(2):513-25.e10. PubMed ID: 26597578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer.
    Kawano T; Nakamura Y; Yanoma S; Kubota A; Furukawa M; Miyagi Y; Tsukuda M
    Auris Nasus Larynx; 2004 Mar; 31(1):35-41. PubMed ID: 15041052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
    Tran TA; Kallakury BV; Sheehan CE; Ross JS
    Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CD44 variant exon 6 in invasion of head and neck squamous cell carcinoma.
    Kanke M; Fujii M; Kameyama K; Kanzaki J; Tokumaru Y; Imanishi Y; Tomita T; Matsumura Y
    Arch Otolaryngol Head Neck Surg; 2000 Oct; 126(10):1217-23. PubMed ID: 11031408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.
    Berner HS; Suo Z; Risberg B; Villman K; Karlsson MG; Nesland JM
    Histopathology; 2003 Jun; 42(6):546-54. PubMed ID: 12786890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis.
    Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM
    Scand J Gastroenterol; 1998 Mar; 33(3):301-9. PubMed ID: 9548625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD44 variant isoforms and association to the benign form of endocrine pancreatic tumours.
    Imam H; Eriksson B; Oberg K
    Ann Oncol; 2000 Mar; 11(3):295-300. PubMed ID: 10811495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological significance of expression of CD44 variants in head and neck squamous cell carcinoma.
    Kanke M; Fujii M; Kameyama K; Kanzaki J; Tokumaru Y; Imanishi Y; Tomita T; Matsumura Y
    Jpn J Cancer Res; 2000 Apr; 91(4):410-5. PubMed ID: 10804289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 loss in gastric stromal tumors as a prognostic marker.
    Montgomery E; Abraham SC; Fisher C; Deasel MR; Amr SS; Sheikh SS; House M; Lilliemoe K; Choti M; Brock M; Ephron DT; Zahuruk M; Chadburn A
    Am J Surg Pathol; 2004 Feb; 28(2):168-77. PubMed ID: 15043305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD44 variants in gastric carcinoma with or without Epstein-Barr virus.
    Chong JM; Fukayama M; Hayashi Y; Funata N; Takizawa T; Koike M; Muraoka M; Kikuchi-Yanoshita R; Miyaki M; Mizuno S
    Int J Cancer; 1997 Aug; 74(4):450-4. PubMed ID: 9291438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of variant CD44 containing variant exon v8-10 in gallbladder cancer.
    Yamaguchi A; Zhang M; Goi T; Fujita T; Niimoto S; Katayama K; Hirose K
    Oncol Rep; 2000; 7(3):541-4. PubMed ID: 10767365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low serum levels of soluble CD44 variant 6 are significantly associated with poor prognosis in patients with pancreatic carcinoma.
    Gansauge F; Gansauge S; Rau B; Scheiblich A; Poch B; Schoenberg MH; Beger HG
    Cancer; 1997 Nov; 80(9):1733-9. PubMed ID: 9351541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
    Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH
    Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of standard and variant CD44 in human lung cancer].
    Zhao H; Fang J; Du G
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):541-3. PubMed ID: 11360506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression tumor stem cell surface marker CD44 in gastric cancer and its significance].
    Xie JW; Huang CM; Zheng CH; Li P; Wang JB; Lin JX; Lu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Nov; 16(11):1107-12. PubMed ID: 24277411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.